Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products

References

• Abbas, Z., J. Yakoob, W. Jafri, Z. Ahmad, Z. Azam, M. W. Usman, S. Shamim, and M. Islam. 2014. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: randomized trial. European Journal of Gastroenterology & Hepatology 26:630–9. doi: 10.1097/MEG.0000000000000094.
   PubMed Web of Science ®Google Scholar
• Adam, J., C. Barret, A. Barret-Bellet, E. Benedetti, A. Calendini, P. Darchen, J. Galibert, P. Guerci, G. Guiot, and M. Haechler. 1977. Controlled double-blind clinical trials of Ultra-Levure: Multicentre study by 25 physicians in 388 cases. Medicine and Chirurgie Digestives 84:2072–8.
   Google Scholar
• Ahmadi, A., E. Milani, A. Madadlou, S. A. Mortazavi, R. R. Mokarram, and D. Salarbashi. 2014. Synbiotic yogurt-ice cream produced via incorporation of microencapsulated lactobacillus acidophilus (la-5) and fructooligosaccharide. Journal of Food Science and Technology 51:1568–74. doi: 10.1007/s13197-012-0679-y.
   PubMed Web of Science ®Google Scholar
• Al-Jailawi, M. H., A. Al-Shekdhaher, and R Al-Zaiadi. 2016. Genetic improvement of Saccharomyces boulardii R7 and generate suitable strains for synthesis and expression of recombinant products. British Biotechnology Journal 11 (2):1–9. doi: 10.9734/BBJ/2016/22927.
   Google Scholar
• Ansari, F., H. Pourjafar, and S. Esmailpour. 2017a. Study on citric acid production and antibacterial activity of kombucha green tea beverage during production and storage. Annual Research & Review in Biology 16 (3):1–8. doi: 10.9734/ARRB/2017/35664.
   Google Scholar
• Ansari, F., H. Pourjafar, V. Jodat, J. Sahebi, and A. Ataei. 2017b. Effect of Eudragit S100 nanoparticles and alginate chitosan encapsulation on the viability of Lactobacillus acidophilus and Lactobacillus rhamnosus. AMB Express 7:144. doi: 10.1186/s13568-017-0442-x.
   PubMed Web of Science ®Google Scholar
• Ansari, F., H. Pourjafar, A. Kangari, and A. Homayouni. 2019. Evaluation of the glucuronic acid production and antibacterial properties of Kombucha Black Tea. Current Pharmaceutical Biotechnology 20:985–90. doi: 10.2174/1389201020666190717100958.
   PubMed Web of Science ®Google Scholar
• Araújo, E. A., A. C. dos Santos Pires, M. S. Pinto, G. Jan, and A. Carvalho. 2012. Chapter 6: Probiotics in dairy fermented products. In Probiotics, ed. E. Rigobelo, 129–48. London: IntechOpen doi: 10.5772/51939..
   Google Scholar
• Arevalo‐Villena, M., A. Briones‐Perez, M. Corbo, M. Sinigaglia, and A. Bevilacqua. 2017. Biotechnological application of yeasts in food science: Starter cultures, probiotics and enzyme production. Journal of Applied Microbiology 123:1360–72. doi: 10.1111/jam.13548.
   PubMed Web of Science ®Google Scholar
• Azhar, S. H. M., R. Abdulla, S. A. Jambo, H. Marbawi, J. A. Gansau, A. A. M. Faik, and K. Rodrigues. 2017. Yeasts in sustainable bioethanol production: A review. Biochemistry and Biophysics Reports 10:52–61. doi: 10.1016/j.bbrep.2017.03.003.
   PubMedGoogle Scholar
• Bafutto, M., J. R. d Almeida, N. V. Leite, M. B. G. Costa, E. C. d Oliveira, and J. Resende-Filho. 2013. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Arquivos de Gastroenterologia 50:304–9. doi: 10.1590/S0004-28032013000400012.
   PubMedGoogle Scholar
• Bahgat, M., A. Maghraby, O. D.-F. Ab, and A. Elshafei. 2005. Immunization of mice with crude extract of Saccharomyces boulardii yeast induces cross-reactive immune responses with antigenic preparations from different developmental stages of the Schistosoma mansoni and reduces the parasite worm burden. Journal of the Egyptian Society of Parasitology 35:563–80.
   PubMedGoogle Scholar
• Bai, F., L. Chen, Z. Zhang, W. Anderson, and M. Moo-Young. 2004. Continuous ethanol production and evaluation of yeast cell lysis and viability loss under very high gravity medium conditions. Journal of Biotechnology 110:287–93. doi: 10.1016/j.jbiotec.2004.01.017.
   PubMed Web of Science ®Google Scholar
• Barnett, J. A. 2000. A history of research on yeasts 2: Louis Pasteur and his contemporaries, 1850–1880. Yeast 16 (8):755–71. doi: 10.1002/1097-0061(20000615)16:8<755::AID-YEA587>3.0.CO;2-4.
   PubMed Web of Science ®Google Scholar
• Barzegari, A., S. Eslami, E. Ghabeli, and Y. Omidi. 2014. Imposition of encapsulated non-indigenous probiotics into intestine may disturb human core microbiome. Frontiers in Microbiology 5:393. doi: 10.3389/fmicb.2014.00393.
   PubMed Web of Science ®Google Scholar
• Beena Divya, J., K. Kulangara Varsha, K. Madhavan Nampoothiri, B. Ismail, and A. Pandey. 2012. Probiotic fermented foods for health benefits. Engineering in Life Sciences 12:377–90. doi: 10.1002/elsc.201100179.
   Web of Science ®Google Scholar
• Berni, R. C., S. Cucchiara, R. Cuomo, F. Pace, and F. Papale. 2011. Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children. European Review for Medical and Pharmacological Sciences 15:809–22.
   PubMed Web of Science ®Google Scholar
• Besirbellioglu, B. A., A. Ulcay, M. Can, H. Erdem, M. Tanyuksel, I. Y. Avci, E. Araz, and A. Pahsa. 2006. Saccharomyces boulardii and infection due to Giardia lamblia. Scandinavian Journal of Infectious Diseases 38:479–81. doi: 10.1080/00365540600561769.
   PubMed Web of Science ®Google Scholar
• Billoo, A. G., M. Memon, S. Khaskheli, G. Murtaza, K. Iqbal, M. S. Shekhani, and A. Q. Siddiqi. 2006. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World Journal of Gastroenterology 12:4557–60. doi: 10.3748/wjg.v12.i28.4557.
   PubMed Web of Science ®Google Scholar
• Bin, Z., X. Ya-Zheng, D. Zhao-Hui, C. Bo, J. Li-Rong, and Y. Vandenplas. 2015. The efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard Helicobacter pylori eradication treatment in children. Pediatric Gastroenterology, Hepatology & Nutrition 18:17–22. doi: 10.5223/pghn.2015.18.1.17.
   PubMed Web of Science ®Google Scholar
• Bisson, J.-F., S. Hidalgo, P. Rozan, and M. Messaoudi. 2010. Preventive effects of different probiotic formulations on travelers’ diarrhea model in wistar rats: Preventive effects of probiotics on TD. Digestive Diseases and Sciences 55:911–9. doi: 10.1007/s10620-009-0822-4.
   PubMed Web of Science ®Google Scholar
• Bleichner, G., H. Blehaut, H. Mentec, and D. Moyse. 1997. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. Intensive Care Medicine 23:517–23. doi: 10.1007/s001340050367.
   PubMed Web of Science ®Google Scholar
• Bourreille, A., G. Cadiot, G. Le Dreau, D. Laharie, L. Beaugerie, J.-L. Dupas, P. Marteau, P. Rampal, D. Moyse, A. Saleh, et al. 2013. Saccharomyces boulardii does not prevent relapse of Crohn’s disease. Clinical Gastroenterology and Hepatology 11:982–7. doi: 10.1016/j.cgh.2013.02.021.
   PubMed Web of Science ®Google Scholar
• Bravo, M. V., D. Bunout, L. Leiva, M. P. de la Maza, G. Barrera, J. de la Maza, and S. Hirsch. 2008. Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment. Revista Médica de Chile 136:981–8.
   PubMed Web of Science ®Google Scholar
• Briand, F., T. Sulpice, P. Giammarinaro, and X. Roux. 2019. Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model. Beneficial Microbes 10:555–67. doi: 10.3920/BM2018.0134.
   PubMed Web of Science ®Google Scholar
• Bruns, R., and R. Raedsch. 1995. Therapy of traveller's diarrhea. Medizinische Welt 46:591–6.
   Web of Science ®Google Scholar
• Buccigrossi, V., G. Laudiero, C. Russo, E. Miele, M. Sofia, M. Monini, F. Ruggeri, and A. Guarino. 2014. Chloride Secretion Induced by Rotavirus Is Oxidative Stress-Dependent and Inhibited by Saccharomyces boulardii in Human Enterocytes. PloS One 9:e99830. doi: 10.1371/journal.pone.0099830.
   PubMed Web of Science ®Google Scholar
• Buts, J. P. 1999. Mechanisms of action of biotherapeutic agents. In Biotherapeutic agents and infectious diseases, G. W. Elmer, L. V. McFarland, C. M. Surawicz, 27–46. Totowa, NJ: Springer.
   Google Scholar
• Buts, J. P., Corthier, G. Delmee. and M. 1993. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. Journal of Pediatric Gastroenterology and Nutrition 16:419–25. doi: 10.1097/00005176-199305000-00013.
   PubMed Web of Science ®Google Scholar
• Can, M., I. Y. Avci, C. M. Beker, and A. Pahsa. 2006. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: A prospective study. Medical Science Monitor 12:PI19–PI22.
   PubMed Web of Science ®Google Scholar
• Capece, A., R. Romaniello, A. Pietrafesa, G. Siesto, R. Pietrafesa, M. Zambuto, and P. Romano. 2018. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added. International Journal of Food Microbiology 284:22–30. doi: 10.1016/j.ijfoodmicro.2018.06.028.
   PubMed Web of Science ®Google Scholar
• Cárdenas, P. A., D. Garcés, B. Prado-Vivar, N. Flores, M. Fornasini, H. Cohen, I. Salvador, O. Cargua, and M. E. Baldeón. 2020. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. European Journal of Clinical Microbiology & Infectious Diseases 39:1365–72. doi: 10.1007/s10096-020-03854-3.
   PubMed Web of Science ®Google Scholar
• Carstensen, J. W., M. Chehri, K. Schønning, S. C. Rasmussen, J. Anhøj, N. S. Godtfredsen, C. Ø. Andersen, and A. M. Petersen. 2018. Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study. European Journal of Clinical Microbiology & Infectious Diseases 37:1431–9. doi: 10.1007/s10096-018-3267-x.
   PubMed Web of Science ®Google Scholar
• Carvalho, A. S., J. Silva, P. Ho, P. Teixeira, F. X. Malcata, and P. Gibbs. 2003. Impedimetric method for estimating the residual activity of freeze-dried Lactobacillus delbrueckii ssp. bulgaricus. International Dairy Journal 13:463–8. doi: 10.1016/S0958-6946(03)00049-9.
   Web of Science ®Google Scholar
• Casem, R. A. O. 2013. Saccharomyces boulardii in the prevention of antibioticassociated diarrhea in children: a randomized controlled trial. Pediatric Infectious Disease Society of the Philippines Journal 14:70–6.
   Google Scholar
• Castagliuolo, I., M. F. Riegler, L. Valenick, J. T. LaMont, and C. Pothoulakis. 1999. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infection and Immunity 67:302–7.
   PubMed Web of Science ®Google Scholar
• Cetina‐Sauri, G., and G. Sierra Basto. 1994. Evaluation of Saccharomyces boulardii for the treatment of acute diarrhea in pediatric patients. Annales de Pediatrie 41 (6):397–400.
   Google Scholar
• Chae, Y. K., S. H. Kim, J. E. Ellinger, and J. L. Markley. 2013. Dosage effects of salt and pH stresses on Saccharomyces cerevisiae as monitored via metabolites by using two dimensional NMR spectroscopy. Bulletin of the Korean Chemical Society 34:3602–8. doi: 10.5012/bkcs.2013.34.12.3602.
   PubMed Web of Science ®Google Scholar
• Chanthala, L., and A. Appaiah. 2014. In vitro probiotic characterization of yeasts of food and environmental origin. International Journal of Probiotics and Prebiotics 9:87–92.
   Google Scholar
• Chen, X., J. Fruehauf, J. D. Goldsmith, H. Xu, K. K. Katchar, H. W. Koon, D. Zhao, E. G. Kokkotou, C. Pothoulakis, and C. P. Kelly. 2009. Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice. Gastroenterology 137:914–23. doi: 10.1053/j.gastro.2009.05.050.
   PubMed Web of Science ®Google Scholar
• Chen, L. S., Y. Ma, J.-L. Maubois, L-j Chen, Q.-H. Liu, and J.-P. Guo. 2010. Identifcation of yeasts from raw milk and selection for some specific antioxidant properties. International Journal of Dairy Technology 63:47–54. doi: 10.1111/j.1471-0307.2009.00548.x.
   Web of Science ®Google Scholar
• Chiron, C., T. A. Tompkins, and P. J. Burguière. 2018. Flow cytometry: a versatile technology for specific quantification and viability assessment of micro‐organisms in multistrain probiotic products. Journal of Applied Microbiology 124:572–84. doi: 10.1111/jam.13666.
   PubMed Web of Science ®Google Scholar
• Choi, C. H., S. Y. Jo, H. J. Park, S. K. Chang, J.-S. Byeon, and S.-J. Myung. 2011. A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: Effect on quality of life. Journal of Clinical Gastroenterology 45:679–83. doi: 10.1097/MCG.0b013e318204593e.
   PubMed Web of Science ®Google Scholar
• Chu, Y., H. Zhu, Y. Zhou, L. Lv, and J. Huo. 2012. Intervention study on Saccharomyces boulardii with proton pump inhibitor (PPI)-based triple therapy for Helicobacter pylori related peptic ulcer. African Journal of Pharmacy and Pharmacology 6:2900–4. doi: 10.5897/AJPP12.400.
   Google Scholar
• Cindoruk, M., G. Erkan, T. Karakan, A. Dursun, and S. Unal. 2007. Efficacy and safety of Saccharomyces boulardii in the 14‐day triple anti‐Helicobacter pylori therapy: A prospective randomized placebo‐controlled double‐blind study. Helicobacter 12:309–16. doi: 10.1111/j.1523-5378.2007.00516.x.
   PubMed Web of Science ®Google Scholar
• Clydesdale, F. M. 1997. A proposal for the establishment of scientific criteria for health claims for functional foods. Nutrition Reviews 55:413–22. doi: 10.1111/j.1753-4887.1997.tb01588.x.
   PubMed Web of Science ®Google Scholar
• Collignon, A., C. Sandre, and M.-C. Barc. 2010. Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment. Gastroentérologie Clinique et Biologique 34:S71–S78. doi: 10.1016/S0399-8320(10)70024-5.
   PubMedGoogle Scholar
• Cremonini, F., S. Di Caro, M. Covino, A. Armuzzi, M. Gabrielli, L. Santarelli, E. C. Nista, G. Cammarota, G. Gasbarrini, and A. Gasbarrini. 2002. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study. The American Journal of Gastroenterology 97:2744–9. doi: 10.1111/j.1572-0241.2002.07063.x.
   PubMed Web of Science ®Google Scholar
• Czerucka, D., L. Ibáñez,, R. Pontier-Bres, F. Larbret, A. Rekima, V. Verhasselt, C. Blin-Wakkach. 2019. Saccharomyces boulardii strain CNCM I-745 modifies the mononuclear phagocytes response in the small intestine of mice following salmonella typhimurium infection. Frontiers in Immunology 10:643. doi: 10.3389/fimmu.2019.00643.
   PubMed Web of Science ®Google Scholar
• Czerucka, D., T. Piche, and P. Rampal. 2007. Review article: yeast as probiotics - Saccharomyces boulardii. Alimentary Pharmacology & Therapeutics 26:767–78. doi: 10.1111/j.1365-2036.2007.03442.x.
   PubMed Web of Science ®Google Scholar
• Czerucka, D., and P. Rampal. 2019. Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections. World Journal of Gastroenterology 25:2188–203. doi: 10.3748/wjg.v25.i18.2188.
   PubMed Web of Science ®Google Scholar
• Da Silva, N., M. H. Taniwaki, V. C. Junqueira, N. Silveira, M. M. Okazaki, and R. A. R. Gomes. 2018. Microbiological examination methods of food and water: A laboratory manual. Boca RAton, FL: CRC Press..
   Google Scholar
• Dalmasso, G., F. Cottrez, V. Imbert, P. Lagadec, J.-F. Peyron, P. Rampal, D. Czerucka, H. Groux, A. Foussat, and V. Brun. 2006. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 131:1812–25. doi: 10.1053/j.gastro.2006.10.001.
   PubMed Web of Science ®Google Scholar
• Das, S., P. K. Gupta, and R. R. Das. 2016. Efficacy and safety of Saccharomyces boulardii in acute rotavirus diarrhea: double blind randomized controlled trial from a developing country. Journal of Tropical Pediatrics 62:464–70. doi: 10.1093/tropej/fmw032.
   PubMed Web of Science ®Google Scholar
• Datta, S., D. J. Timson, and U. S. Annapure. 2017. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii. Journal of the Science of Food and Agriculture 97:3039–49. doi: 10.1002/jsfa.8147.
   PubMed Web of Science ®Google Scholar
• de la Cruz-Gavia, A., C. Pérez-Alonso, C. Barrera-Díaz, J. Alvarez-Ramírez, H. Carrillo-Navas, and A. Guadarrama-Lezama. 2018. Survival of Saccharomyces cerevisiae microencapsulated with complex coacervate after freezing process. Food Hydrocolloids 82:45–52. doi: 10.1016/j.foodhyd.2018.03.045.
   Web of Science ®Google Scholar
• De Llanos, R., A. Querol, J. Pemán, M. Gobernado, and M. T. Fernández-Espinar. 2006. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. International Journal of Food Microbiology 110:286–90. doi: 10.1016/j.ijfoodmicro.2006.04.023.
   PubMed Web of Science ®Google Scholar
• De Marco, S., M. Sichetti, D. Muradyan, M. Piccioni, G. Traina, R. Pagiotti, and D. Pietrella. 2018. Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS. Evidence-Based Complementary and Alternative Medicine 2018: 1756308. doi: 10.1155/2018/1756308.
   PubMed Web of Science ®Google Scholar
• de Oliveira Ribeiro, A. P., F. dos Santos Gomes, K. M. O. dos Santos, V. M. da Matta, D. de Grandi CastroFreitas de Sá, M. C. P. de AraujoSantiago, C. Conte, S. D. de Oliveira Costa, L. de Oliveira Ribeiro, R. L. de Oliveira Godoy, et al. 2020. Development of a probiotic non-fermented blend beverage with juçara fruit: Effect of the matrix on probiotic viability and survival to the gastrointestinal tract. LWT 118:108756. doi: 10.1016/j.lwt.2019.108756.
   Web of Science ®Google Scholar
• De Ruiter, G. A., S. W. Notermans, and F. M. J. T. Rombouts. 1993. New methods in food mycology. Trends in Food Science & Technology 4:91–7. doi: 10.1016/0924-2244(93)90089-S.
   Web of Science ®Google Scholar
• Deak, T., and L. Beuchat. 1993. Evaluation of the indirect conductance method for the detection of yeasts in laboratory media and apple juice. Food Microbiology 10:255–62. doi: 10.1006/fmic.1993.1029.
   Web of Science ®Google Scholar
• Deak, T., and L. Beuchat. 1995. Modified indirect conductimetric technique for detecting low populations of yeasts in beverage concentrates and carbonated beverages. Food Microbiology 12:165–72. doi: 10.1016/S0740-0020(95)80093-X.
   Web of Science ®Google Scholar
• Dendukuri, N., V. Costa, M. McGregor, and J. M. Brophy. 2005. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: A systematic review. Canadian Medical Association Journal 173:167–70. doi: 10.1503/cmaj.050350.
   PubMed Web of Science ®Google Scholar
• Díaz, M., M. Herrero, L. A. García, and C. Quirós. 2010. Application of flow cytometry to industrial microbial bioprocesses. Biochemical Engineering Journal 48:385–407. doi: 10.1016/j.bej.2009.07.013.
   Web of Science ®Google Scholar
• Dinleyici, E. C., M. Eren, N. Dogan, S. Reyhanioglu, Z. A. Yargic, and Y. Vandenplas. 2011. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitology Research 108:541–5. doi: 10.1007/s00436-010-2095-4.
   PubMed Web of Science ®Google Scholar
• Dinleyici, E. C., M. Eren, Z. A. Yargic, N. Dogan, and Y. Vandenplas. 2009. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. The American Journal of Tropical Medicine and Hygiene 80:953–5. doi: 10.4269/ajtmh.2009.80.953.
   PubMed Web of Science ®Google Scholar
• Dinleyici, E. C., A. Kara, N. Dalgic, Z. Kurugol, V. Arica, O. Metin, E. Temur, O. Turel, S. Guven, O. Yasa, et al. 2015. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea. Beneficial Microbes 6:415–21. doi: 10.3920/BM2014.0086.
   PubMed Web of Science ®Google Scholar
• Diplock, A., J.-L. Charuleux, G. Crozier-Willi, F. Kok, C. Rice-Evans, M. Roberfroid, W. Stahl, and J. Vina-Ribes. 1998. Functional food science and defence against reactive oxidative species. British Journal of Nutrition 80:S77–S112. doi: 10.1079/BJN19980106.
   PubMed Web of Science ®Google Scholar
• Douradinha, B., V. C. Reis, M. B. Rogers, F. A. Torres, J. D. Evans, and E. T. Marques Jr. 2014. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii. Bioengineered 5 (1):21–9. doi: 10.4161/bioe.26271.
   PubMed Web of Science ®Google Scholar
• Drozdova, P. B., O. V. Tarasov, A. G. Matveenko, E. A. Radchenko, J. V. Sopova, D. E. Polev, S. G. Inge-Vechtomov, and P. V. Dobrynin. 2016. Genome sequencing and comparative analysis of Saccharomyces cerevisiae strains of the Peterhof genetic collection. PloS One 5:e0154722. 11 doi: 10.1371/journal.pone.0154722.
   Google Scholar
• Du, L. P., R. X. Hao, D. G. Xiao, L. L. Guo, and W. D. Gai. 2012. Research on the characteristics and culture conditions of Saccharomyces boulardii. Advanced Materials Research 343–344:594–8. doi: 10.4028/www.scientific.net/AMR.343-344.594.
   Google Scholar
• Duman, D. G., S. Bor, O. Ozütemiz, T. Sahin, D. Oğuz, F. Iştan, T. Vural, M. Sandkci, F. Işksal, I. Simşek, et al. 2005. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. European Journal of Gastroenterology & Hepatology 17:1357–61. doi: 10.1097/00042737-200512000-00015.
   PubMed Web of Science ®Google Scholar
• Duman, D. G., Z. N. Ö. Kumral, F. Ercan, M. Deniz, G. Can, and B. Cağlayan Yeğen. 2013. Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats. The British Journal of Nutrition (3)110:493–9. doi: 10.1017/S000711451200517X.
   PubMed Web of Science ®Google Scholar
• Edwards-Ingram, L., P. Gitsham, N. Burton, G. Warhurst, I. Clarke, D. Hoyle, S. G. Oliver, and L. Stateva. 2007. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Applied and Environmental Microbiology 73:2458–67. doi: 10.1128/AEM.02201-06.
   PubMed Web of Science ®Google Scholar
• Ehrhardt, S., N. Guo, R. Hinz, S. Schoppen, J. May, M. Reiser, M. P. Schroeder, S. Schmiedel, M. Keuchel, E. C. Reisinger, et al. 2016. Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial. Open Forum Infectious Diseases 3 (1):ofw011. doi: 10.1093/ofid/ofw011.
   PubMed Web of Science ®Google Scholar
• Elmer, G., L. McFarland, C. Surawicz, L. Danko, and R. Greenberg. 1999. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Alimentary Pharmacology & Therapeutics 13:1663–8. doi: 10.1046/j.1365-2036.1999.00666.x.
   PubMed Web of Science ®Google Scholar
• Endo, A., and M. Gueimonde. 2016. Isolation, identification and characterisation of potential new probiotics. Advances in probiotic technology. Abingdon: Taylor and Francis Group.
   Google Scholar
• Erdoğan, Ö., B. Tanyeri, E. Torun, E. Gönüllü, H. Arslan, U. Erenberk, and F. Öktem. 2012. The comparition of the efficacy of two different probiotics in rotavirus gastroenteritis in children. Journal of Tropical Medicine 2012:787240. doi: 10.1155/2012/787240.
   PubMedGoogle Scholar
• Fakruddin, M., M. N. Hossain, and M. M. Ahmed. 2017. Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic. BMC Complementary and Alternative Medicine 17 (1):64. doi: 10.1186/s12906-017-1591-9.
   PubMedGoogle Scholar
• Fakruddin, M., M. A. Islam, M. M. Ahmed, and N. J. Chowdhury. 2013. Process optimization of bioethanol production by stress tolerant yeasts isolated from agro-industrial waste. International Journal of Renewable and Sustainable Energy 2 (4):133–9. doi: 10.11648/j.ijrse.20130204.11.
   Google Scholar
• Fang, G., Z. Li, C. Su, and G. Hu. 2017. Clinical observation of saccharomyces boulardii combined with cetirizine hydrochloride in children allergic rhinitis. Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery 31:1649–52.
   Google Scholar
• FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food. https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
   Google Scholar
• Farache, J., I. Koren, I. Milo, I. Gurevich, K.-W. Kim, E. Zigmond, G. C. Furtado, S. A. Lira, and G. Shakhar. 2013. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 38:581–95. doi: 10.1016/j.immuni.2013.01.009.
   PubMed Web of Science ®Google Scholar
• Fidan, I., A. Kalkanci, E. Yesilyurt, B. Yalcin, B. Erdal, S. Kustimur, and T. Imir. 2009. Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans. Mycoses 52:29–34. doi: 10.1111/j.1439-0507.2008.01545.x.
   PubMed Web of Science ®Google Scholar
• Fietto, J. L., R. S. Araújo, F. N. Valadão, L. G. Fietto, R. L. Brandão, M. J. Neves, F. C. Gomes, J. R. Nicoli, and I. M. Castro. 2004. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Canadian Journal of Microbiology 50:615–21. doi: 10.1139/w04-050.
   PubMed Web of Science ®Google Scholar
• Fleet, G. H., and M. J. Mian. 1987. The occurrence and growth of yeasts in dairy products. International Journal of Food Microbiology 4:145–55. doi: 10.1016/0168-1605(87)90021-3.
   Web of Science ®Google Scholar
• Fortin, O., B. Aguilar-Uscanga, K. D. Vu, S. Salmieri, and M. Lacroix. 2018a. Cancer chemopreventive, antiproliferative, and superoxide anion scavenging properties of Kluyveromyces marxianus and Saccharomyces cerevisiae var. boulardii cell wall components. Nutrition and Cancer 70:83–96. doi: 10.1080/01635581.2018.1380204.
   PubMed Web of Science ®Google Scholar
• Fortin, O., B. R. Aguilar-Uscanga, K. D. Vu, S. Salmieri, and M. Lacroix. 2018b. Effect of Saccharomyces boulardii cell wall extracts on colon cancer prevention in male F344 rats treated with 1,2-Dimethylhydrazine. Nutrition and Cancer 70:632–42. doi: 10.1080/01635581.2018.1460672.
   PubMed Web of Science ®Google Scholar
• Fung, D. Y. F. 2002. Predictions for rapid methods and automation in food microbiology. Journal of AOAC International 85:1000–2. doi: 10.1093/jaoac/85.4.1000.
   PubMed Web of Science ®Google Scholar
• Ganguly, R., R. Chakraborty, and K. Sarkar. 2019. Inulin Induced Co-Aggregation of Saccharomyces boulardii with Potential Pathogenic Bacteria. International Journal of Probiotics & Prebiotics 14 (1):18–23.
   Google Scholar
• Gaon, D., H. Garcia, L. Winter, N. Rodríguez, R. Quintas, S. N. Gonzalez, and G. Oliver. 2003. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 63:293–8.
   PubMed Web of Science ®Google Scholar
• Garcia Vilela, E., M. De Lourdes De Abreu Ferrari, H. Oswaldo Da Gama Torres, A. Guerra Pinto, A. Carolina Carneiro Aguirre, F. Paiva Martins, E. Marcos Andrade Goulart, and A. Sales Da Cunha. 2008. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scandinavian Journal of Gastroenterology 43:842–8. doi: 10.1080/00365520801943354.
   PubMed Web of Science ®Google Scholar
• García, G., M. E. Agosto, L. Cavaglieri, and C. Dogi. 2020. Effect of fermented whey with a probiotic bacterium on gut immune system. Journal of Dairy Research 87:134–7. doi: 10.1017/S0022029919000980.
   PubMed Web of Science ®Google Scholar
• Ghasemnezhad, R., V. Razavilar, H. Pourjafar, K. Khosravi-Darani, and K. Ala. 2017. The viability of free and encapsulated Lactobacillus casei and Bifidobacterium animalis in chocolate milk, and evaluation of its pH changes and sensory properties during storage. Annual Research & Review in Biology 21 (3):1–8. doi: 10.9734/ARRB/2017/37885.
   Google Scholar
• Ghorbani-Choboghlo, H., D. Nikaein, A. Khosravi, R. Rahmani, and Z. Farahnejad. 2019. Effect of microencapsulation on Saccharomyces cerevisiae var. boulardii viability in the gastrointestinal tract and level of some blood biochemical factors in wistar rats. Iranian Journal of Microbiology 11:160–5. doi: 10.18502/ijm.v11i2.1082.
   PubMed Web of Science ®Google Scholar
• Ghorbani-Choboghlo, H., T. Zahraei-Salehi, J. Ashrafi-Helan, R. Yahyaraeyat, H. Pourjafar, D. Nikaein, A. Balal, and A.-R. Khosravi. 2015. Microencapsulation of Saccharomyces cerevisiae and its evaluation to protect in simulated gastric conditions. Iranian Journal of Microbiology 7:338.
   PubMedGoogle Scholar
• Giang, H. H., T. Q. Viet, B. Ogle, and J. E. Lindberg. 2012. Growth performance, digestibility, gut environment and health status in weaned piglets fed a diet supplemented with a complex of lactic acid bacteria alone or in combination with Bacillus subtilis and Saccharomyces boulardii. Livestock Science 143:132–41. doi: 10.1016/j.livsci.2011.09.003.
   Web of Science ®Google Scholar
• Girard, P., Y. Pansart, and M. Verleye. 2014. Anti-Hypercholesterolemic Effect of Saccharomyces boulardii in the Hamster. Pharmacology 94:239–44. doi: 10.1159/000365009.
   PubMed Web of Science ®Google Scholar
• Giudici, P., G. Masini, and C. Caggia. 2003. The role of galactose fermenting yeast in plain yogurt spoilageet. Annali di Microbiologia ed Enzimologia 46 (1):11–9.
   Google Scholar
• Goffeau, A., B. G. Barrell, H. Bussey, R. W. Davis, B. Dujon, H. Feldmann, F. Galibert, J. D. Hoheisel, C. Jacq, M. Johnston, et al. 1996. Life with 6000 genes. Science 274:546–67. doi: 10.1126/science.274.5287.546.
   PubMed Web of Science ®Google Scholar
• Goodenough, E., and D. Kleyn. 1976. Qualitative and quantitative changes in carbohydrates during the manufacture of Yogurt1. Journal of Dairy Science 59:45–7. doi: 10.3168/jds.S0022-0302(76)84153-7.
   PubMed Web of Science ®Google Scholar
• Graff, S., J.-C. Chaumeil, P. Boy, R. Lai-Kuen, and C. Charrueau. 2008. Influence of pH conditions on the viability of Saccharomyces boulardii yeast. The Journal of General and Applied Microbiology 54:221–7. doi: 10.2323/jgam.54.221.
   PubMed Web of Science ®Google Scholar
• Granato, D., G. F. Branco, A. G. Cruz, J. d A. F. Faria, and N. P. Shah. 2010a. Probiotic dairy products as functional foods. Comprehensive Reviews in Food Science and Food Safety 9:455–70. doi: 10.1111/j.1541-4337.2010.00120.x.
   PubMed Web of Science ®Google Scholar
• Granato, D., G. F. Branco, F. Nazzaro, A. G. Cruz, and J. A. Faria. 2010b. Functional foods and nondairy probiotic food development: Trends, concepts, and products. Comprehensive Reviews in Food Science and Food Safety 9:292–302. doi: 10.1111/j.1541-4337.2010.00110.x.
   PubMed Web of Science ®Google Scholar
• Guo, X., R. Long, M. Kreuzer, L. Ding, Z. Shang, Y. Zhang, Y. Yang, and G. Cui. 2014. Importance of functional ingredients in yak milk-derived food on health of Tibetan nomads living under high-altitude stress: a review. Critical Reviews in Food Science and Nutrition 54:292–302. doi: 10.1080/10408398.2011.584134.
   PubMed Web of Science ®Google Scholar
• Guslandi, M. 2015. Role of probiotics in Crohn’s disease and in Pouchitis. Journal of Clinical Gastroenterology 49:S46–S49. doi: 10.1097/MCG.0000000000000351.
   PubMed Web of Science ®Google Scholar
• Guslandi, M., G. Mezzi, M. Sorghi, and P. A. Testoni. 2000. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Digestive Diseases and Sciences 45:1462–4. doi: 10.1023/A:1005588911207.
   PubMed Web of Science ®Google Scholar
• Hamedi, H., A. Misaghi, M. H. Modarressi, T. Z. Salehi, D. Khorasanizadeh, and V. Khalaj. 2013. Generation of a uracil auxotroph strain of the probiotic yeast Saccharomyces boulardii as a host for the recombinant protein production. Avicenna Journal of Medical Biotechnology 5 (1):29–34.
   PubMedGoogle Scholar
• Heling, A. L., O. J. Kuhn, J. R. Stangarlin, N. P. Henkemeier, S. Coltro-Roncato, and E. D. V. Gonçalves. 2017. Controle biológico de antracnose em pós colheita de banana “Maçã” com Saccharomyces spp. Summa Phytopathologica 43:49–51. doi: 10.1590/0100-5405/2105.
   Google Scholar
• Hennequin, C., C. Kauffmann-Lacroix, A. Jobert, J. Viard, C. Ricour, J. Jacquemin, and P. Berche. 2000. Possible role of catheters in Saccharomyces boulardii fungemia. European Journal of Clinical Microbiology & Infectious Diseases 19 (1):16–20. doi: 10.1007/s100960050003.
   PubMed Web of Science ®Google Scholar
• Heydari, S., A. M. Mortazavian, M. R. Ehsani, M. A. Mohammadifar, and H. Ezzatpanah. 2011. Biochemical, microbiological and sensory characteristics of probiotic yogurt containing various prebiotic compounds. Italian Journal of Food Science 23 (2):153–64.
   Web of Science ®Google Scholar
• Hill, C., F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein, B. Pot, L. Morelli, R. B. Canani, H. J. Flint, S. Salminen, et al. 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11:506–14. doi: 10.1038/nrgastro.2014.66.
   PubMed Web of Science ®Google Scholar
• Holzapfel, W. H., P. Haberer, R. Geisen, J. Björkroth, and U. Schillinger. 2001. Taxonomy and important features of probiotic microorganisms in food and nutrition. The American Journal of Clinical Nutrition 73:365S–73s. doi: 10.1093/ajcn/73.2.365s.
   PubMed Web of Science ®Google Scholar
• Holzapfel, W. H., P. Haberer, J. Snel, U. Schillinger, and J. H. Huis in't Veld. 1998. Overview of gut flora and probiotics. International Journal of Food Microbiology 41:85–101. doi: 10.1016/S0168-1605(98)00044-0.
   PubMed Web of Science ®Google Scholar
• Homayouni, A., F. Ansari, A. Azizi, H. Pourjafar, and M. Madadi. 2020a. Cheese as a potential food carrier to deliver probiotic microorganisms into the human gut: a review. Current Nutrition & Food Science 16:15–28. doi: 10.2174/1573401314666180817101526.
   Web of Science ®Google Scholar
• Homayouni, A., A. Azizi, M. Ehsani, M. Yarmand, and S. Razavi. 2008. Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream. Food Chemistry 111:50–5. doi: 10.1016/j.foodchem.2008.03.036.
   Web of Science ®Google Scholar
• Homayouni, A., M. Javadi, F. Ansari, H. Pourjafar, M. Jafarzadeh, and A. Barzegar. 2018. Advanced methods in ice cream analysis: A review. Food Analytical Methods 11:3224–34. doi: 10.1007/s12161-018-1292-0.
   Web of Science ®Google Scholar
• Homayouni, A., R. R. Mokarram, S. Norouzi, A. Dehnad, A. Barkhordari, H. Homayouni, and H. Pourjafar. 2020b. Soy ice cream as a carrier for efficient delivering of Lactobacillus casei. Nutrition & Food Science 51 (1):61–70. doi: 10.1108/NFS-11-2019-0349.
   Web of Science ®Google Scholar
• Hossain, M. N., S. Afrin, S. Humayun, M. M. Ahmed, and B. K. Saha. 2020. Identification and Growth Characterization of a Novel Strain of Saccharomyces boulardii Isolated From Soya Paste. Frontiers in Nutrition 7:27. doi: 10.3389/fnut.2020.00027.
   PubMed Web of Science ®Google Scholar
• Htwe, K., K. S. Yee, M. Tin, and Y. Vandenplas. 2008. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. The American Journal of Tropical Medicine and Hygiene 78:214–6. doi: 10.4269/ajtmh.2008.78.214.
   PubMed Web of Science ®Google Scholar
• Hudson, L. E., M. B. Fasken, C. D. McDermott, S. M. McBride, E. G. Kuiper, D. B. Guiliano, A. H. Corbett, and T. J. Lamb. 2014. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii. Plos One 9 (11):e112660. doi: 10.1371/journal.pone.0112660.
   PubMed Web of Science ®Google Scholar
• Hudson, L. E., C. D. McDermott, T. P. Stewart, W. H. Hudson, D. Rios, M. B. Fasken, A. H. Corbett, and T. J. Lamb. 2016. Characterization of the probiotic yeast Saccharomyces boulardii in the healthy mucosal immune system. PloS One 11:e0153351. doi: 10.1371/journal.pone.0153351.
   PubMed Web of Science ®Google Scholar
• Huq, T., A. Khan, R. A. Khan, B. Riedl, and M. Lacroix. 2013. Encapsulation of probiotic bacteria in biopolymeric system. Critical Reviews in Food Science and Nutrition 53:909–16. doi: 10.1080/10408398.2011.573152.
   PubMed Web of Science ®Google Scholar
• Im, E., and C. Pothoulakis. 2010. Recent advances in Saccharomyces boulardii research. Gastroentérologie Clinique et Biologique 34:S62–S70. doi: 10.1016/S0399-8320(10)70023-3.
   PubMedGoogle Scholar
• Jack, L., F. Coyer, M. Courtney, and B. Venkatesh. 2010. Probiotics and diarrhoea management in enterally tube fed critically ill patients-what is the evidence? Intensive & Critical Care Nursing 26:314–26. doi: 10.1016/j.iccn.2010.07.001.
   PubMedGoogle Scholar
• Jakobsen, M., and J. Narvhus. 1996. Yeasts and their possible beneficial and negative effects on the quality of dairy products. International Dairy Journal 6:755–68. doi: 10.1016/0958-6946(95)00071-2.
   Web of Science ®Google Scholar
• Jay, J. M., M. J. Loessner, and D. A. Golden. 2008. Modern food microbiology. New York: Springer Science & Business Media.
   Google Scholar
• Jayan, H., H. Pu, and D. W. Sun. 2019. Recent development in rapid detection techniques for microorganism activities in food matrices using bio-recognition: A review. Trends in Food Science & Technology 95:233–46. doi: 10.1016/j.tifs.2019.11.007.
   Web of Science ®Google Scholar
• Johansson, M. E., and G. C. Hansson. 2016. Immunological aspects of intestinal mucus and mucins. Nature Reviews Immunology 16:639–49. doi: 10.1038/nri.2016.88.
   PubMed Web of Science ®Google Scholar
• Joossens, S., P. Suenaert, M. Noman, S. Vermeire, and P. Rutgeerts. 2005. Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability. Inflammatory Bowel Disease 11:863–4. doi: 10.1097/01.mib.0000183543.72225.08.
   PubMed Web of Science ®Google Scholar
• Justino, P. F. C., A. X. Franco, R. Pontier-Bres, C. E. S. Monteiro, A. L. R. Barbosa, M. H. L. P. Souza, D. Czerucka, and P. M. G. Soares. 2020. Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic. Cytokine 125:154791. doi: 10.1016/j.cyto.2019.154791.
   PubMed Web of Science ®Google Scholar
• Kabbani, T. A., K. Pallav, S. E. Dowd, J. Villafuerte-Galvez, R. R. Vanga, N. E. Castillo, J. Hansen, M. Dennis, D. A. Leffler, and C. P. Kelly. 2017. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes 8:17–32. doi: 10.1080/19490976.2016.1267890.
   PubMed Web of Science ®Google Scholar
• Kabir, M., S. Ishaque, M. Ali, M. Mahmuduzzaman, and M. Hasan. 2011. Role of Saccharomyces boulardii in diarrhea predominant irritable bowel syndrome. Mymensingh Medical Journal 20:397–401.
   PubMedGoogle Scholar
• Kelesidis, T., and C. Pothoulakis. 2012. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology 5:111–25. doi: 10.1177/1756283X11428502.
   PubMed Web of Science ®Google Scholar
• Kelly, C. P., C. Chong Nguyen, L. J. Palmieri, K. Pallav, S. E. Dowd, L. Humbert, P. Seksik, A. Bado, B. Coffin, D. Rainteau, et al. 2019. Saccharomyces boulardii CNCM I-745 modulates the fecal bile acids metabolism during antimicrobial therapy in healthy volunteers. Frontiers in Microbiology 10:336. doi: 10.3389/fmicb.2019.00336.
   PubMed Web of Science ®Google Scholar
• Khaneghah, A. M., K. Abhari, I. Eş, M. B. Soares, R. B. A. Oliveira, H. Hosseini, M. Rezaei, C. F. Balthazar, R. Silva, A. G. Cruz, et al. 2020. Interactions between probiotics and pathogenic microorganisms in hosts and foods: A review. Trends in Food Science & Technology 95:205–18. doi: 10.1016/j.tifs.2019.11.022.
   Web of Science ®Google Scholar
• Khatri, I., R. Tomar, K. Ganesan, G. Prasad, and S. Subramanian. 2017. Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii. Scientific Reports 7 (1):12. doi: 10.1038/s41598-017-00414-2.
   PubMedGoogle Scholar
• Khidhr, K. O., and Z. M. A. Zubaidy. 2014. Isolation and Identification of Saccharomyces cerevisiae var boulardii and its Uses as a Probiotic (in vitro). Rafidain Journal of Science 25:1–11.
   Google Scholar
• Kimmey, M. B., G. W. Elmer, C. M. Surawicz, and L. V. McFarland. 1990. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Digestive Diseases and Sciences 35:897–901. doi: 10.1007/BF01536805.
   PubMed Web of Science ®Google Scholar
• Kirchhelle, A., N. Frühwein, and D. Tobüren. 1996. Treatment of persistent diarrhea with S. boulardii in returning travelers. Results of a prospective study. Fortschritte er Medizin 114:136–40.
   PubMedGoogle Scholar
• Klein, S. M., G. W. Elmer, L. V. McFarland, C. M. Surawicz, and R. H. Levy. 1993. Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharmaceutical Research 10:1615–9. doi: 10.1023/A:1018924820333.
   PubMed Web of Science ®Google Scholar
• Kollaritsch, H., H. Holst, P. Grobara, and G. Wiedermann. 1993. Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschritte er Medizin 111:152–6.
   PubMedGoogle Scholar
• Kollaritsch, H., P. Kremsner, G. Wiedermann, and O. Scheiner. 1989. Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparations. The International Society of Travel Medicine 6:9–17. https://www.epistemonikos.org/en/documents/48dcb727175962d03a2d93c03aaac160633c6e3a.
   Google Scholar
• Koon, H. W., B. Su, C. Xu, C. C. Mussatto, D. H.-N. Tran, E. C. Lee, C. Ortiz, J. Wang, J. E. Lee, S. Ho, et al. 2016. Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters. American Journal of Physiology 311:G610–G623. doi: 10.1152/ajpgi.00150.2016.
   Google Scholar
• Kreger-van Rij, N. J. W. 2013. The yeasts: a taxonomic study. Amsterdam: Elsevier.
   Google Scholar
• Kuda, T., H. Takahashi, and B. Kimura. 2016. Alcohol-brewing properties of acid-and bile-tolerant yeasts co-cultured with lactic acid bacteria isolated from traditional handmade domestic dairy products from Inner Mongolia. LWT - Food Science and Technology 65:62–9. doi: 10.1016/j.lwt.2015.07.065.
   Web of Science ®Google Scholar
• Kurugöl, Z., and G. Koturoğlu. 2005. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatrica 94:44–7. doi: 10.1080/08035250410022521.
   PubMed Web of Science ®Google Scholar
• Kyriakos, N., K. Papamichael, A. Roussos, I. Theodoropoulos, C. Karakoidas, A. Smyrnidis, E. Archavlis, K. Lariou, and G. J. Mantzaris. 2013. A lyophilized form of Saccharomyces boulardii enhances the Helicobacter pylori eradication rates of omeprazole-triple therapy in patients with peptic ulcer disease or functional dyspepsia. Hospital Chronicles 8:127–33.
   Google Scholar
• Lang, F., and A. Lang. 1975. Acidophilus milk products: little known cultured milks of great potential. Milk Industry 77 (3):4–5. https://agris.fao.org/agris-search/search.do?recordID=CZ19760058818.
   Google Scholar
• Lara-Hidalgo, C., L. Dorantes-Álvarez, H. Hernández-Sánchez, F. Santoyo-Tepole, A. Martínez-Torres, L. Villa-Tanaca, and C. Hernández-Rodríguez. 2019. Isolation of yeasts from Guajillo Pepper (Capsicum annuum L.) fermentation and study of some probiotic characteristics. Probiotics Antimicrob Proteins 11:748–64. doi: 10.1007/s12602-018-9415-x.
   PubMed Web of Science ®Google Scholar
• Lazo‐Vélez, M., S. Serna‐Saldívar, M. Rosales‐Medina, M. Tinoco‐Alvear, and and M. Briones‐García. 2018. Application of Saccharomyces cerevisiae var. boulardii in food processing: A review. Journal of Applied Microbiology 125:943–51.
   PubMed Web of Science ®Google Scholar
• Le, B. L., G. Makhoul, and J. Duhamel. 2010. A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea. Archives de Pédiatrie 17:459–65.
   PubMed Web of Science ®Google Scholar
• Lee, S. K., H. J. Kim, and S. G. Chi. 2010. Saccharomyces boulardii reduced intestinal inflammation in mice model of 2,4,6-trinitrobencene sulfonic acid induced colitis: Based on microarray. The Korean Journal of Gastroenterology 55:33–45. doi: 10.4166/kjg.2010.55.1.33.
   PubMedGoogle Scholar
• Lei, Z., H. Chen, D. Huang, Y. Zhai, and S. Guowei. 2016. Optimization of medium compositions for Saccharomyces boulardii by box-behnken design. Scientific Study and Research: Chemistry and Chemical Engineering. Biotechnology, Food Industry 17:405–16.
   Google Scholar
• Leventogiannis, K., P. Gkolfakis, G. Spithakis, A. Tsatali, A. Pistiki, A. Sioulas, E. J. Giamarellos-Bourboulis, and K. Triantafyllou. 2019. Effect of a preparation of four probiotics on symptoms of patients with irritable bowel syndrome: association with intestinal bacterial overgrowth. Probiotics Antimicrob Proteins 11:627–34. doi: 10.1007/s12602-018-9401-3.
   PubMed Web of Science ®Google Scholar
• Lewis, S., L. Potts, and R. Barry. 1998. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. Journal of Infection 36:171–4. doi: 10.1016/S0163-4453(98)80008-X.
   PubMed Web of Science ®Google Scholar
• Liboredo, J. C., L. R. Anastácio, M. d C. G. Pelúzio, F. X. Valente, L. C. P. Penido, J. R. Nicoli, and M. I. T. D. Correia. 2013. Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon. Acta Cirurgica Brasileira 28:367–72. doi: 10.1590/S0102-86502013000500008.
   PubMed Web of Science ®Google Scholar
• Liu, J.-J., I. I. Kong, G.-C. Zhang, L. N. Jayakody, H. Kim, P.-F. Xia, S. Kwak, B. H. Sung, J.-H. Sohn, H. E. Walukiewicz, et al. 2016. Metabolic engineering of probiotic Saccharomyces boulardii. Applied and Environmental Microbiology 82:2280–7. doi: 10.1128/AEM.00057-16.
   PubMed Web of Science ®Google Scholar
• Lourens-Hattingh, A., and B. Viljoen. 2001. Growth and survival of a probiotic yeast in dairy products. Food Research International 34:791–6. doi: 10.1016/S0963-9969(01)00085-0.
   Web of Science ®Google Scholar
• Malviya, A., S. Malviya, A. Agarwal, M. Mishra, and V. Dalmida. 2019. Saccharomyces‐eukaryotic probiotic for human applications. In A handbook on high value fermentation products, volume 2: Human welfare, ed. S. Saran, V. Babu, A. Chaubey, 211. Hoboken: Wiley.
   Google Scholar
• Mansour-Ghanaei, F., N., Dehbashi, K. Yazdanparast, and A. Shafaghi. 2003. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World Journal of Gastroenterology 9:1832. doi: 10.3748/wjg.v9.i8.1832.
   PubMed Web of Science ®Google Scholar
• Marshall, D. L., and J. K. Odame-Darkwah. 1995. Influence of pH and NaCl on growth and survival of Propionibacterium freudenreichii subsp. shermanii, Bacillus pumilus, and Saccharomyces cerevisiae in broth media. LWT - Food Science and Technology 28:222–6. doi: 10.1016/S0023-6438(95)91554-0.
   Google Scholar
• Marteau, P. 2001. Safety aspects of probiotic products. Näringsforskning 45:22–4. doi: 10.3402/fnr.v45i0.1785.
   Google Scholar
• Martins, F. S., A. A. Silva, A. T. Vieira, F. H. Barbosa, R. M. Arantes, M. M. Teixeira, and J. R. Nicoli. 2009. Comparative study of Bifidobacteriumanimalis, Escherichiacoli, Lactobacilluscasei and Saccharomycesboulardii probiotic properties. Archives of Microbiology 191:623–30. doi: 10.1007/s00203-009-0491-x.
   PubMed Web of Science ®Google Scholar
• Maupas, J., P. Champemont, and M. Delforge. 1983. Treatment of irritable bowel syndrome. Double blind trial of Saccharomyces boulardii. Medecine et Chirurgie Digestives 12:77–9.
   Google Scholar
• McCullough, M. J., K. V. Clemons, J. H. McCusker, and D. A. Stevens. 1998. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval). Journal of Clinical Microbiology 36:2613–7. doi: 10.1128/JCM.36.9.2613-2617.1998.
   PubMed Web of Science ®Google Scholar
• McFarland, L. 2017. Common organisms and probiotics: Saccharomyces boulardii. In The Microbiota in Gastrointestinal Pathophysiology, ed. M. H. Floch, Y. Ringel, and W. Allan Walker, 145–64. Amsterdam: Elsevier.
   Google Scholar
• McFarland, L. V. 1996. Saccharomyces boulardii is not Saccharomyces cerevisiae. Clinical Infectious Diseases 22:200–1. doi: 10.1093/clinids/22.1.200.
   PubMed Web of Science ®Google Scholar
• McFarland, L. V. 2009. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe 15:274–80. doi: 10.1016/j.anaerobe.2009.09.002.
   PubMed Web of Science ®Google Scholar
• McFarland, L. V. 2010. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology 16:2202. doi: 10.3748/wjg.v16.i18.2202.
   PubMed Web of Science ®Google Scholar
• McFarland, L. V. 2015. From yaks to yogurt: The history, development, and current use of probiotics. Clinical Infectious Diseases 60:S85–S90. doi: 10.1093/cid/civ054.
   PubMed Web of Science ®Google Scholar
• McFarland, L. V., and P. Bernasconi. 1993. Saccharomyces boulardii. A review of an innovative biotherapeutic agent. Microbial Ecology in Health and Disease 6:157–71. doi: 10.3109/08910609309141323.
   Web of Science ®Google Scholar
• McFarland, L. V., C. M. Surawicz, R. N. Greenberg, G. W. Elmer, K. A. Moyer, S. A. Melcher, K. E. Bowen, and J. L. Cox. 1995. Prevention of b-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. American Journal of Gastroenterology 90:439–48.
   PubMed Web of Science ®Google Scholar
• McFarland, L. V., C. M. Surawicz, R. N. Greenberg, R. Fekety, G. W. Elmer, K. A. Moyer, S. A. Melcher, K. E. Bowen, J. L. Cox, and Z. Noorani. 1994. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271:1913–8. doi: 10.1001/jama.1994.03510480037031.
   PubMed Web of Science ®Google Scholar
• Menezes, A. G. T., C. L. Ramos, G. Cenzi, D. S. Melo, D. R. Dias, and R. F. Schwan. 2019. Probiotic potential, antioxidant activity, and phytase production of indigenous yeasts isolated from indigenous fermented foods. Probiotics and Antimicrobial Proteins 12(1):280–288.
   Web of Science ®Google Scholar
• Metchnikoff, E. 1907. Lactic acid as inhibiting intestinal putrefaction. In The prolongation of life optimistic studies, ed. P. Chalmers Mitchell, 161–83. London: W. Heinemann.
   Google Scholar
• Micklefield, G. J. 2014. Saccharomyces boulardii bei Antibiotika-assoziierter Diarrhöe. MMW - Fortschritte Der Medizin 156:18–22. doi: 10.1007/s15006-014-2878-0.
   PubMedGoogle Scholar
• Mirzaei, H., H. Pourjafar, and A. H. Rad. 2011. The effect of microencapsulation with calcium alginate and resistant starch on the Lactobacillus acidophilus (La5) survival rate in simulated gastrointestinal juice conditions. Journal of Veterinary Research 66:337–77.
   Google Scholar
• Mitterdorfer, G., H. Mayer, W. Kneifel, and H. Viernstein. 2002. Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. Journal of Applied Microbiology 93 (4):521–30. doi: 10.1046/j.1365-2672.2002.01710.x.
   PubMed Web of Science ®Google Scholar
• Moayyedi, P., A. C. Ford, N. J. Talley, F. Cremonini, A. E. Foxx-Orenstein, L. J. Brandt, and E. M. Quigley. 2010. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 59:325–32. doi: 10.1136/gut.2008.167270.
   PubMed Web of Science ®Google Scholar
• Mohammadi, R., and A. Mortazavian. 2011. Technological aspects of prebiotics in probiotic fermented milks. Food Reviews International 27 (2):192–212. doi: 10.1080/87559129.2010.535235.
   Web of Science ®Google Scholar
• Monteiro, E., J. P. Fernandes, M. R. Vieira, J. P. Correia, J. M. Caetano, T. Ribeiro, A. B. Antunes, R. Noronha, F. Batista, L. Reis, et al. 1981. Double blind clinical trial on the use of ultra-levure in the prophylaxis of antibiotic induced gastro-intestinal and mucocutaneous disorders. Acta Médica Portuguesa 3 (2):143–5.
   PubMedGoogle Scholar
• Moradi, R., R. Nosrati, H. Zare, T. Tahmasebi, H. Saderi, and P. Owlia. 2018. Screening and characterization of in-vitro probiotic criteria of Saccharomyces and Kluyveromyces strains. International Journal of Microbiology 10:123–131.
   Google Scholar
• Moslemi, M., R. Mazaheri Nezhad Fard, S. Hosseini, A. Homayouni-Rad, and A. M. Mortazavian. 2016. Incorporation of propionibacteria in fermented milks as a probiotic. Critical Reviews in Food Science and Nutrition 56(8):1290–312. doi: 10.1080/10408398.2013.766584.
   PubMed Web of Science ®Google Scholar
• Mousa, A. H., G. Wang, and H. Zhang. 2019. Morphological and molecular tools for identification of Saccharomyces boulardii isolated from active dry yeast. International Journal of Agriculture Innovations and Research 7 (4):2319–1473.
   Google Scholar
• Nagashima, A. I., P. E. Pansiera, M. M. Baracat, and R. J. H. C. Gómez. 2013. Development of effervescent products, in powder and tablet form, supplemented with probiotics Lactobacillus acidophilus and Saccharomyces boulardii. Food Science and Technology (Campinas) 33:605–11. doi: 10.1590/S0101-20612013000400002.
   Google Scholar
• Nami, Y., R. Vaseghi Bakhshayesh, H. Mohammadzadeh Jalaly, H. Lotfi, S. Eslami, and M. A. Hejazi. 2019. Probiotic properties of Enterococcus isolated from artisanal dairy products. Frontiers in Microbiology 10:300. doi: 10.3389/fmicb.2019.00300.
   PubMed Web of Science ®Google Scholar
• Namkin, K., M. Zardast, and F. Basirinejad. 2016. Saccharomyces boulardii in Helicobacter Pylori eradication in children: a randomized trial from Iran. Iranian Journal of Pediatrics 26 (1):e3768. doi: 10.5812/ijp.3768.
   PubMed Web of Science ®Google Scholar
• Naumova, E., A. Z. Sadykova, N. Martynenko, and G. Naumov. 2013. Molecular genetic characteristics of Saccharomyces cerevisiae distillers’ yeasts. Microbiology 82:175–85. doi: 10.1134/S0026261713020112.
   Web of Science ®Google Scholar
• Nevitt, T., J. Pereira, D. Azevedo, P. Guerreiro, and C. Rodrigues-Pousada. 2004. Expression of YAP4 in Saccharomyces cerevisiae under osmotic stress. Biochemical Journal 379:367–74. doi: 10.1042/BJ20031127.
   PubMed Web of Science ®Google Scholar
• Niamah, A. 2017. Physicochemical and microbial characteristics of yogurt added with Saccharomyces Boulardii. Current Research in Nutrition and Food Science Journal 5:300–7. doi: 10.12944/CRNFSJ.5.3.15.
   Web of Science ®Google Scholar
• Niamah, A. K., A. J. Al-Manhel, and S. T. G. Al-Sahlany. 2018. Effect microencapsulation of Saccharomyces boulardii on viability of yeast in vitro and ice cream. The Carpathian Journal of Food Science and Technology 10:111–8. http://chimie-biologie.ubm.ro/carpathian_journal/index.html.
   Web of Science ®Google Scholar
• Niamah, A. K., A. A. Sahi, and A. S. Al-Sharifi. 2017. Effect of feeding soy milk fermented by probiotic bacteria on some blood criteria and weight of experimental animals. Probiotics Antimicrob Proteins 9:284–91. doi: 10.1007/s12602-017-9265-y.
   PubMed Web of Science ®Google Scholar
• Norouzi, S., H. Pourjafar, F. Ansari, and A. Homayouni. 2019. A Survey on the survival of Lactobacillus paracasei in fermented and non-fermented frozen soy dessert. Biocatalysis and Agricultural Biotechnology 21:101297. doi: 10.1016/j.bcab.2019.101297.
   Web of Science ®Google Scholar
• Offei, B., P. Vandecruys, S. De Graeve, M. R. Foulquié-Moreno, and J. M. Thevelein. 2019. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii. Genome Research 29 (9):1478–94. doi: 10.1101/gr.243147.118.
   PubMed Web of Science ®Google Scholar
• Ozkan, T., E. Sahin, G. Erdemir, and F. Budak. 2007. Effect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune response. Journal of International Medical Research 35:201–12. doi: 10.1177/147323000703500204.
   PubMed Web of Science ®Google Scholar
• Pandiyan, C., and G. Kumaresan. 2013. Utilization of probiotic yeast Saccharomyces Boulardii in dairy products-a overview. In Probiotics in sustainable food production: Current status and future prospects - probiotic foods, ed. A. Ramanathan and T. Senthivel, 57–60. Coimbatore: Bonfring.
   Google Scholar
• Pandiyan, C., R. A. Villi, G. Kumaresan, B. Murugan, and T. Gopalakrishnamurthy. 2012. Development of synbiotic ice cream incorporating Lactobacillus acidophilus and Saccharomyces boulardii. International Food Research Journal 19:1233.
   Google Scholar
• Pardo, S., M. A. Galvagno, and P. Cerrutti. 2009. Studies of viability and vitality after freezing of the probiotic yeast Saccharomyces boulardii: physiological preconditioning effect. Revista Iberoamericana de Micologia 26:155–60.
   PubMed Web of Science ®Google Scholar
• Paula, B. P. D., D. W. H. Chávez, L. Junior, W. J. Fernandes, A. F. Guerra, M. F. D. Corrêa, K. S. Pereira, and M. A. Z. Coelho. 2019. Growth parameters and survivability of Saccharomyces boulardii for probiotic alcoholic beverages development. Frontiers in Microbiology 10:2092. doi: 10.3389/fmicb.2019.02092.
   PubMed Web of Science ®Google Scholar
• Peng, M., P. Patel, V. Nagarajan, C. Bernhardt, M. Carrion, and D. Biswas. 2019. Feasible options to control colonization of enteric pathogens with designed synbiotics Dietary Interventions in Gastrointestinal Diseases, 135–49. Amsterdam: Elsevier.
   Google Scholar
• Peng, M., Z. Tabashsum, M. Anderson, A. Truong, A. K. Houser, J. Padilla, A. Akmel, J. Bhatti, S. O. Rahaman, and D. Biswas. 2020. Effectiveness of probiotics, prebiotics, and prebiotic‐like components in common functional foods. Comprehensive Reviews in Food Science and Food Safety 19 (4):1908–33. doi: 10.1111/1541-4337.12565.
   PubMed Web of Science ®Google Scholar
• Pettipher, G. 1991. Preliminary evaluation of flow cytometry for the detection of yeasts in soft drinks. Letters in Applied Microbiology 12:109–12. doi: 10.1111/j.1472-765X.1991.tb00517.x.
   Web of Science ®Google Scholar
• Piatek, J., H. Sommermeyer, A. Ciechelska-Rybarczyk, and M. Bernatek. 2019. In-vitro pathogen inhibition: Comparing the inhibitory effects of a complex multistrain synbiotic with simple probiotics containing the yeast Saccharomyces boulardii or Lactobacillus rhamnosus bacteria. BioRxiv 543819. doi: 10.1101/543819..
   Google Scholar
• Picó-Monllor, J. A., and J. M. Mingot-Ascencao. 2019. Search and selection of probiotics that improve mucositis symptoms in oncologic patients. Nutrients 11:2322. doi: 10.3390/nu11102322.
   PubMed Web of Science ®Google Scholar
• Plein, K., and J. Hotz. 1993. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea–a pilot study. Zeitschrift ur Gastroenterologie 31:129–34.
   PubMed Web of Science ®Google Scholar
• Postollec, F., H. Falentin, S. Pavan, J. Combrisson, and D. Sohier. 2011. Recent advances in quantitative PCR (qPCR) applications in food microbiology. Food Microbiology 28:848–61. doi: 10.1016/j.fm.2011.02.008.
   PubMed Web of Science ®Google Scholar
• Pourjafar, H., N. Noori, H. Gandomi, and A. A. Basti. 2016. Study of protective role of double coated beads of calcium alginate-chitosan-eudragit S100 nanoparticles achieved from microencapsulation of Lactobacillus acidophilus as a predominant flora of human and animals gut. Journal of Veterinary Research 71 (3):311–20. doi: 10.22059/JVR.2016.58729.
   Google Scholar
• Pourjafar, H., N. Noori, H. Gandomi, A. A. Basti, and F. Ansari. 2018. Stability and efficiency of double-coated beads containing lactobacillus acidophilus obtained from the calcium alginate-chitosan and eudragit S100 nanoparticles microencapsulation. International Journal of Probiotics & Prebiotics 13:77–84.
   Google Scholar
• Pourjafar, H., N. Noori, H. Gandomi, A. A. Basti, and F. Ansari. 2020. Viability of microencapsulated and non-microencapsulated Lactobacilli in a commercial beverage. Biotechnology Reports 25:e00432. doi: 10.1016/j.btre.2020.e00432.
   Google Scholar
• Pozzoni, P., A. Riva, A. G. Bellatorre, M. Amigoni, E. Redaelli, A. Ronchetti, M. Stefani, R. Tironi, E. E. Molteni, D. Conte, et al. 2012. Saccharomyces boulardiifor the prevention of antibiotic-associated diarrhea in adult hospitalized patients: A single-center, randomized, double-blind, placebo-controlled trial. American Journal of Gastroenterology 107:922–31. doi: 10.1038/ajg.2012.56.
   PubMed Web of Science ®Google Scholar
• Qamar, A., S. Aboudola, M. Warny, P. Michetti, C. Pothoulakis, J. T. LaMont, and C. P. Kelly. 2001. Saccharomyces boulardii stimulates intestinal immunoglobulin a immune response to clostridium difficiletoxin a in mice. Infection and Immunity 69:2762–5. doi: 10.1128/IAI.69.4.2762-2765.2001.
   PubMed Web of Science ®Google Scholar
• Ragavan, M. L., and N. Das. 2017. Molecular identification of probiotic yeast strains and their characterization. Asian Journal of Pharmaceutical and Clinical Research 10:339–43. doi: 10.22159/ajpcr.2017.v10i10.20052.
   Google Scholar
• Rajkowska, K., A. Kunicka-Styczyńska, and A. Rygala. 2012. Probiotic activity of Saccharomyces cerevisiae var. boulardii against human pathogens. Food Technology and Biotechnology 50:230–6.
   Web of Science ®Google Scholar
• Rattray, J., A. Schibeci, and D. K. Kidby. 1975. Lipids of yeasts. Bacteriological Reviews 39 (3):197–231. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413914/. doi: 10.1128/MMBR.39.3.197-231.1975.
   PubMedGoogle Scholar
• Reethu Narayanan, N. R. K., and P. J. J. Ch. 2012. Evaluation of probiotic potential of stress tolerant Saccharomyces cerevisiae and development of economically viable media for maximum growth. Journal of Food Processing & Technology 3 (2)https://agris.fao.org/agris-search/search.do?recordID=US2016B00418.
   Google Scholar
• Riaz, M., S. Alam, A. Malik, and S. M. Ali. 2012. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial. European Journal of Gastroenterology & Hepatology 79:478–82. doi: 10.1007/s12098-011-0573-z.
   Google Scholar
• Ribeiro, M., D. Oliveira, F. Oliveira, M. Caliari, F. Martins, J. Nicoli, M. Torres, M. Andrade, V. Cardoso, and M. Gomes. 2018. Effect of probiotic Saccharomyces boulardii in experimental giardiasis. Beneficial Microbes 9:789–97. doi: 10.3920/BM2017.0155.
   PubMed Web of Science ®Google Scholar
• Roos, T. B., C. M. de Moraes, R. T. Sturbelle, L. A. Dummer, G. Fischer, and F. P. L. Leite. 2018. Probiotics Bacillus toyonensis and Saccharomyces boulardii improve the vaccine immune response to Bovine herpesvirus type 5 in sheep. Research in Veterinary Science 117:260–5. doi: 10.1016/j.rvsc.2017.12.022.
   PubMed Web of Science ®Google Scholar
• Roostita, R., and G. Fleet. 1996. The occurrence and growth of yeasts in Camembert and blue-veined cheeses. International Journal of Food Microbiology 28:393–404. doi: 10.1016/0168-1605(95)00018-6.
   PubMed Web of Science ®Google Scholar
• Rozee, K., D. Cooper, K. Lam, and J. Costerton. 1982. Microbial flora of the mouse ileum mucous layer and epithelial surface. Applied and Environmental Microbiology (6)43:1451–63. doi: 10.1128/aem.43.6.1451-1463.1982.
   PubMed Web of Science ®Google Scholar
• Ruyssen, T., G. Vlaemynck, M. Uyttendaele, P. Van Assche, and T. Le Trung. 2007. Flow cytometry as a rapid tool for microbiological analysis in the food industry: Potentials and restrictions rapid methods for food and feed quality determination, 85–101. Wageningen: Wageningen Academic Publishers.
   Google Scholar
• Ryan, J., D. Hanes, M. Schafer, J. Mikolai, and H. Zwickey. 2015. Effect of the probiotic Saccharomyces boulardii on cholesterol and lipoprotein particles in hypercholesterolemic adults: a single-arm, open-label pilot study. Journal of Alternative and Complementary Medicine 21:288–93. doi: 10.1089/acm.2014.0063.
   PubMed Web of Science ®Google Scholar
• Ryan, E. P., A. L. Heuberger, T. L. Weir, B. Barnett, C. D. Broeckling, and J. E. Prenni. 2011. Rice bran fermented with Saccharomyces boulardii generates novel metabolite profiles with bioactivity. Journal of Agricultural and Food Chemistry 59:1862–70. doi: 10.1021/jf1038103.
   PubMed Web of Science ®Google Scholar
• Saint-Marc, T., H. Blehaut, C. Musial, and J. Touraine. 1995. AIDS-related diarrhea: A double-blind trial of Saccharomyces boulardii. Semaine es Hopitaux de Paris 71:735–41.
   Google Scholar
• Salimi, M., and M. Mahzonieh. 2015. Preparation of proper culture medium for Saccharomyces cerevisiae var. boulardii with Molasses and Animal Serum. Journal of Medical Microbiology and Infectious Diseases 3:18–22.
   Google Scholar
• Santino, I., A. Alari, S. Bono, E. Teti, M. Marangi, A. Bernardini, L. Magrini, S. Di Somma, and A. Teggi. 2014. Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. International Journal of Immunopathology and Pharmacology 27:143–6. doi: 10.1177/039463201402700120.
   PubMed Web of Science ®Google Scholar
• Sardonini, C. A., and D. DiBiasio. 1987. A model for growth of Saccharomyces cerevisiae containing a recombinant plasmid in selective media. Biotechnology and Bioengineering 29:469–75. doi: 10.1002/bit.260290410.
   PubMed Web of Science ®Google Scholar
• Schlotterer, M., P. Bernasconi, F. Lebreton, and D. Wassermann. 1987. Value of Saccharomyces boulardii in the digestive acceptability of continuous-flow enteral nutrition in burnt patients. Nutrition Clinique et Métabolisme 1:31–4. doi: 10.1016/S0985-0562(87)80016-X.
   Google Scholar
• Schneider, S. M., F. Girard-Pipau, J. Filippi, X. Hébuterne, D. Moyse, G. C. Hinojosa, A. Pompei, and P. Rampal. 2005. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World Journal of Gastroenterology 11:6165–9. doi: 10.3748/wjg.v11.i39.6165.
   PubMed Web of Science ®Google Scholar
• Schwenzer, B. 1998. Saccharomyces boulardii. Deutsche Apotheker-Zeitung 138:75–7.
   Google Scholar
• Seddik, H., H. Boutallaka, I. Elkoti, F. Nejjari, R. Berraida, S. Berrag, K. Loubaris, S. Sentissi, and A. Benkirane. 2019. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial. European Journal of Clinical Pharmacology 75:639–45. doi: 10.1007/s00228-019-02625-0.
   PubMed Web of Science ®Google Scholar
• Shah, N. P. 2000. Probiotic bacteria: selective enumeration and survival in dairy foods. Journal of Dairy Science 83:894–907. doi: 10.3168/jds.S0022-0302(00)74953-8.
   PubMed Web of Science ®Google Scholar
• Shan, L.-S., P. Hou, Z.-J. Wang, F.-R. Liu, N. Chen, L.-H. Shu, H. Zhang, X.-H. Han, X.-X. Han, X.-X. Cai, et al. 2013. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Beneficial Microbes 4:329–34. doi: 10.3920/BM2013.0008.
   PubMed Web of Science ®Google Scholar
• Sharif, M. R., H. H. Kashani, A. T. Ardakani, D. Kheirkhah, F. Tabatabaei, and A. Sharif. 2016. The effect of a yeast probiotic on acute diarrhea in children. Probiotics and antimicrobial proteins. Probiotics and Antimicrobial Proteins 8:211–4. doi: 10.1007/s12602-016-9221-2.
   PubMed Web of Science ®Google Scholar
• Silley, P., and S. Forsythe. 1996. Impedance microbiology—a rapid change for microbiologists. Journal of Applied Bacteriology 80:233–243..
   Google Scholar
• Silva, J. F. M. d., J. M. Peluzio, G. Prado, J. E. G. C. Madeira, M. O. Silva, P. B. de Morais, C. A. Rosa, R. S. Pimenta, and J. R. Nicoli. 2015. Use of probiotics to control aflatoxin production in peanut grains. The Scientific World Journal 2015:959138. doi: 10.1155/2015/959138.
   Google Scholar
• Silveira, M. M., F. R. Conceição, M. Mendonça, G. M. S. G. Moreira, C. E. P. Da Cunha, N. L. Conrad, P. D. de Oliveira, D. D. Hartwig, P. M. M. De Leon, and Â. N. Moreira. 2017. Saccharomyces boulardii improves humoral immune response to DNA vaccines against leptospirosis. Journal of Medical Microbiology 66:184–90. doi: 10.1099/jmm.0.000414.
   PubMed Web of Science ®Google Scholar
• Song, M. J., D. I. Park, J. H. Park, H. J. Kim, Y. K. Cho, C. I. Sohn, W. K. Jeon, and B. I. Kim. 2010. The effect of probiotics and mucoprotective agents on PPI‐based triple therapy for eradication of Helicobacter pylori. Helicobacter 15:206–13. doi: 10.1111/j.1523-5378.2010.00751.x.
   PubMed Web of Science ®Google Scholar
• Soukoulis, C., I. D. Fisk, and T. Bohn. 2014. Ice cream as a vehicle for incorporating Health-Promoting Ingredients: Conceptualization and overview of quality and storage stability. Comprehensive Reviews in Food Science and Food Safety 13:627–55. doi: 10.1111/1541-4337.12083.
   PubMed Web of Science ®Google Scholar
• Speck, M. L. 1984. Compendium of methods for the microbiological examination of foods. Washington, DC: American Public Health Association. https://ajph.aphapublications.org/doi/book/102105/MBEF.0222.
   Google Scholar
• Stadie, J., A. Gulitz, M. A. Ehrmann, and R. F. Vogel. 2013. Metabolic activity and symbiotic interactions of lactic acid bacteria and yeasts isolated from water kefir. Food Microbiology 35:92–8. doi: 10.1016/j.fm.2013.03.009.
   PubMed Web of Science ®Google Scholar
• Stier, H., and S. Bischoff. 2017. Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system. MMW - Fortschritte der Medizin 159:1–6. doi: 10.1007/s15006-017-9802-3.
   PubMedGoogle Scholar
• Sulik-Tyszka, B., E. Snarski, M. Niedźwiedzka, M. Augustyniak, T. N. Myhre, A. Kacprzyk, E. Swoboda-Kopeć, M. Roszkowska, J. Dwilewicz-Trojaczek, W. W. Jędrzejczak, et al. 2018. Experience with Saccharomyces boulardii probiotic in oncohaematological patients. Probiotics Antimicrob Proteins 10:350–5. doi: 10.1007/s12602-017-9332-4.
   PubMed Web of Science ®Google Scholar
• Sultana, A., A. Miyamoto, Q. L. Hy, Y. Tanaka, Y. Fushimi, and H. Yoshii. 2017. Microencapsulation of flavors by spray drying using Saccharomyces cerevisiae. Journal of Food Engineering 199:36–41. doi: 10.1016/j.jfoodeng.2016.12.002.
   Web of Science ®Google Scholar
• Surawicz, C. M., L. V. McFarland, G. Elmer, and J. Chinn. 1989. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. American Journal of Gastroenterology 84:1285–7.
   PubMed Web of Science ®Google Scholar
• Surawicz, C. M., L. V. McFarland, R. N. Greenberg, M. Rubin, R. Fekety, M. E. Mulligan, R. J. Garcia, S. Brandmarker, K. Bowen, D. Borjal, et al. 2000. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clinical Infectious Diseases 31:1012–7. doi: 10.1086/318130.
   PubMed Web of Science ®Google Scholar
• Suriyarachchi, V., and G. Fleet. 1981. Occurrence and growth of yeasts in yogurts. Applied and Environmental Microbiology (4)42:574–9. doi: 10.1128/aem.42.4.574-579.1981.
   PubMed Web of Science ®Google Scholar
• Suryavanshi, A., A. Agarwal, A. Kaler, U. Bihade, J. Kaur, K. Tikoo, and U. Banerjee. 2013. Comparative studies on the antioxidant potential of vanillin-producing Saccharomyces boulardii extracts. Oxidants and Antioxidants in Medical Science 2 (3):201–9. doi: 10.5455/oams.190413.or.040.
   Google Scholar
• Syal, P., and A Vohra. 2013. Probiotic potential of yeasts isolated from traditional Indian fermented foods. International Journal of Microbiology Research 5:390–8. doi: 10.9735/0975-5276.5.2.390-398.
   Google Scholar
• Szajewska, H., and J. Mrukowicz. 2005. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology & Therapeutics 22 (5):365–72. doi: 10.1111/j.1365-2036.2005.02624.x.
   PubMed Web of Science ®Google Scholar
• Tabrizi, A., L. Khalili, A. Homayouni-Rad, H. Pourjafar, P. Dehghan, and F. Ansari. 2019. Prebiotics, as promising functional food to patients with psychological disorders: A review on mood disorders, sleep, and cognition. NeuroQuantology 17 (6):1–9. doi: 10.14704/nq.2019.17.6.2189.
   Google Scholar
• Tang, C., and Z. Lu. 2019. Health promoting activities of probiotics. Journal of Food Biochemistry (8)43:e12944 doi: 10.1111/jfbc.12944.
   PubMed Web of Science ®Google Scholar
• Tanner, R., C.-J. Wei, and J. Woodward. 1981. The development of a semi-solid fermentation system for the production of lysine-enriched yeast and ethanol Scientific and Engineering Principles, 323–8. Amsterdam: Elsevier.
   Google Scholar
• Tempe, J., A. Steidel, H. Blehaut, M. Hasselmann, P. Lutun, and F. Maurier. 1983. Prevention of diarrhea administering Saccharomyces boulardii during continuous enteral feeding. La semaine des hopitaux: organe fonde par. l'Association d'enseignement medical des hopitaux de Paris 59:1409–12. https://pubmed.ncbi.nlm.nih.gov/6306827/.
   Google Scholar
• Tempest, D., J. Meers, and C. Brown. 1970. Influence of environment on the content and composition of microbial free amino acid pools. Journal of General Microbiology (2)64:171–85. doi: 10.1099/00221287-64-2-171.
   PubMedGoogle Scholar
• Tiencheu, B., E. Ngongang, B. Fossi, G. Nchanji, D. Shiynyuy, F. Mbiapo, and Z. François. 2016. Isolation and identification of cholesterol lowering probiotic yeast from palm Raffia (Raffia mambillensis) Wine. Journal of Advances in Biology & Biotechnology 11:1–17. doi: 10.9734/JABB/2017/30469.
   Google Scholar
• Tomičić, Z., R. Colovic, I. Cabarkapa, D. Vukmirovic, O. Djuragic, and R. Tomicic. 2016. Beneficial properties of probiotic yeast Saccharomyces boulardii. Food and Feed Research 43:103–10. doi: 10.5937/FFR1602103T.
   Google Scholar
• Trigueros, D., M. Fiorese, A. Kroumov, C. Hinterholz, B. Nadai, and G. Assunção. 2016. Medium optimization and kinetics modeling for the fermentation of hydrolyzed cheese whey permeate as a substrate for Saccharomyces cerevisiae var. boulardii. Biochemical Engineering Journal 110:71–83. doi: 10.1016/j.bej.2016.02.014.
   Web of Science ®Google Scholar
• Tripathi, M. K., and S. K. Giri. 2014. Probiotic functional foods: Survival of probiotics during processing and storage. Journal of Functional Foods 9:225–41. doi: 10.1016/j.jff.2014.04.030.
   Web of Science ®Google Scholar
• Trotta, F., G. Caldini, L. Dominici, E. Federici, R. Tofalo, M. Schirone, A. Corsetti, G. Suzzi, and G. Cenci. 2012. Food borne yeasts as DNA-bioprotective agents against model genotoxins. International Journal of Food Microbiology (3)153:275–80. doi: 10.1016/j.ijfoodmicro.2011.11.009.
   PubMed Web of Science ®Google Scholar
• Urganci, N., T. Polat, M. Uysalol, and F. Çetinkaya. 2001. Evaluation of the efficacy of Saccharomyces boulardii in children with acute diarrhoea. Archives of Gastroenterohepatology 20:81–3.
   Google Scholar
• Van der Aa Kühle, A., K. Skovgaard, and L. Jespersen. 2005. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. International Journal of Food Microbiology 101:29–39. doi: 10.1016/j.ijfoodmicro.2004.10.039.
   PubMed Web of Science ®Google Scholar
• Vasiljevic, T., and N. P. Shah. 2008. Probiotics—from Metchnikoff to bioactives. International Dairy Journal 18:714–28. doi: 10.1016/j.idairyj.2008.03.004.
   Web of Science ®Google Scholar
• Vinderola, C. G., P. Mocchiutti, and J. A. Reinheimer. 2002. Interactions among lactic acid starter and probiotic bacteria used for fermented dairy products. Journal of Dairy Science (4)85:721–9. doi: 10.3168/jds.S0022-0302(02)74129-5.
   PubMed Web of Science ®Google Scholar
• Wang, G., and D. Feng. 2019. Therapeutic effect of Saccharomyces boulardii combined with Bifidobacterium and on cellular immune function in children with acute diarrhea. Experimental and Therapeutic Medicine 18:2653–9. doi: 10.3892/etm.2019.7836.
   PubMed Web of Science ®Google Scholar
• Wang, X., and H. Yang. 2017. Application of modern new technology in food microbiological detection. Engineering and Technology Research 652–5. doi: 10.12783/dtetr/mcee2017/15823.
   Google Scholar
• Wei, C.-J., R. D. Tanner, and G. W. Malaney. 1982. Effect of sodium chloride on bakers' yeast growing in gelatin. Applied and Environmental Microbiology (4)43:757–63. doi: 10.1128/aem.43.4.757-763.1982.
   PubMed Web of Science ®Google Scholar
• Whelan, K. 2007. Enteral-tube-feeding diarrhoea: Manipulating the colonic microbiota with probiotics and prebiotics: BAPEN Symposium 2 on ‘Pre-and probiotics. The Proceedings of the Nutrition Society 66:299–306. doi: 10.1017/S0029665107005551.
   PubMed Web of Science ®Google Scholar
• Wilkinson, M. G. 2018. Flow cytometry as a potential method of measuring bacterial viability in probiotic products: a review. Trends in Food Science & Technology 78:1–10. doi: 10.1016/j.tifs.2018.05.006.
   Web of Science ®Google Scholar
• Wu, X., B. A. Vallance, L. Boyer, K. S. Bergstrom, J. Walker, K. Madsen, J. R. O'Kusky, A. M. Buchan, and K. Jacobson. 2008. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. American Journal of Physiology 294:G295–G306. doi: 10.1152/ajpgi.00173.2007.
   PubMed Web of Science ®Google Scholar
• Zamora-Vega, R., J. L. Montañez-Soto, J. Venegas-González, A. Bernardino-Nicanor, L. G. Cruz, and H. E. Martínez-Flores. 2013. Development and characterization of a symbiotic cheese added with Saccharomyces boulardii and inulin. African Journal of Microbiology Research 7:2828–34.
   Google Scholar
• Zhao, H., H. Ou-Yang, B. Duan, B. Xu, Z. Chen, J. Tang, and J. You. 2014. Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children. Chinese ournal of Contemporary Pediatrics 16:230–3.
   Google Scholar
• Zojaji, H., M. Ghobakhlou, H. Rajabalinia, E. Ataei, S. J. Sherafat, B. Moghimi-Dehkordi, and R. Bahreiny. 2013. The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H. pylori: A randomized controlled trial. Gastroenterology and Epatology from Bed to Bench 6:S99.
   PubMedGoogle Scholar